Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessandra Crescimanno
Observed names:
A Crescimanno,
A. Crescimanno,
Crescimanno, Alessandra
Institution:
La Maddalena
Observed institutions:
University of Palermo,
La Maddalena,
University of Palermo
OpenAlex ID:
A5075436840
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy
2014
·
C Girmenia
, G M Rossolini
, et al.
·
Bone Marrow Transplantation
·
206
PDF
Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans Syndrome
1998
·
M Musso
, F Porretto
, et al.
·
Lupus
·
76
Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma
2011
·
Immacolata Attolico
, Vincenzo Pavone
, et al.
·
Transplantation and Cellular Therapy
·
75
PDF
JAK2V617F allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy
2016
·
G Barosi
, C Klersy
, et al.
·
Leukemia
·
53
Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy
2008
·
Maurizio Musso
, Renato Scalone
, et al.
·
Supportive Care in Cancer
·
50
Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study
2009
·
M Musso
, R Scalone
, et al.
·
Bone Marrow Transplantation
·
48
PDF
Crohn’s disease complicated by relapsed extranodal Hodgkin’s lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant
2000
·
M Musso
, F Porretto
, et al.
·
Bone Marrow Transplantation
·
42
Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT
2009
·
M Musso
, R Scalone
, et al.
·
Bone Marrow Transplantation
·
38
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
2021
·
Massimo Martino
, Annalisa Pitino
, et al.
·
Frontiers in Oncology
·
32
PDF
Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease
2001
·
Maurizio Musso
, Ferdinando Porretto
, et al.
·
American Journal of Hematology
·
26
PDF
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia
1998
·
R Scimè
, A Indovina
, et al.
·
Bone Marrow Transplantation
·
26
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients: A Phase II Study
2015
·
Maurizio Musso
, Giuseppe Messina
, et al.
·
Transplantation and Cellular Therapy
·
25
PDF
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine‐based high‐dose chemotherapy regimen
2015
·
Maurizio Musso
, Giuseppe Messina
, et al.
·
British Journal of Haematology
·
21
PDF
Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation
2004
·
M Musso
, F Porretto
, et al.
·
Bone Marrow Transplantation
·
18
Successful treatment of resistant thrombotic thrombocytopenic purpura/hemolytic uremic syndrome with autologous peripheral blood stem and progenitor (CD34+) cell transplantation
1999
·
M Musso
, F Porretto
, et al.
·
Bone Marrow Transplantation
·
13
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real‐world study
2020
·
Emilio Iannitto
, Alessandra Romano
, et al.
·
European Journal Of Haematology
·
11
Polatuzumab vedotin–containing regimens as bridge to CART: analysis from the CART-SIE study
2026
·
Giulia Gabrielli
, Beatrice Casadei
, et al.
·
Blood Advances
·
4
PDF
Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemia.
1997
·
M Musso
, F Porretto
, et al.
·
PubMed
·
4
Allogeneic hematopoietic stem cell transplantation for aggressive lymphomas
2014
·
Maurizio Musso
, Renato Scalone
, et al.
·
Drugs and Cell Therapies in Hematology
·
1
Mobilizing Chemotherapy Followed by G-CSF, Additioned by Plerixafor on Demand, Is Safe and Allows Both Adequate PBSC (Peripheral Blood Stem Cell) Collection and Safe ASCT (Autologous Stem Cell Transplantation) In Multiple Myeloma and Lymphoma Patients
2010
·
Immacolata Attolico
, Vincenzo Pavone
, et al.
·
Blood
·
1
Correspondence
1998
·
M Musso
, F Porretto
, et al.
·
Leukemia Research
·
1
68 O - Maintenance low-dose (LD) oral idarubicin (oIDA) in elderly patients (pts) with acute myelogeneous leukemia (AML)
1996
·
M. Musso
, F. Porretto
, et al.
·
European Journal of Cancer
·
1
ANLL patients with normal karyotype are not a homogeneous prognostic group.
1992
·
S Mirto
, A Santoro
, et al.
·
PubMed
·
1
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare ( GITMO ) GVHD24 Study
2025
·
Nicola Polverelli
, Caterina Zerbi
, et al.
·
American Journal of Hematology
447 | Polatuzumab‐containing Regimens as Bridge to Car‐t: Insights From the Italian Car T‐sie Study
2025
·
G. Gabrielli
, B. Casadei
, et al.
·
Hematological Oncology
PDF
Show more works
View as search
Works count:
33
Citation count:
773
H-index:
14
I10-index:
16
Year
Topic
Type